Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Upper respiratory tract illnesses have been associated with an increased risk of ischemic heart disease and stroke. During two influenza seasons, we assessed the influence of vaccination against influenza on the risk of hospitalization for heart disease and stroke, hospitalization for pneumonia and influenza, and death from all causes. METHODS: Cohorts of community-dwelling members of three large managed-care organizations who were at least 65 years old were studied during the 1998-1999 and 1999-2000 influenza seasons. Administrative and clinical data were used to evaluate outcomes, with multivariable logistic regression to control for base-line demographic and health characteristics of the subjects. RESULTS: There were 140,055 subjects in the 1998-1999 cohort and 146,328 in the 1999-2000 cohort, of which 55.5 percent and 59.7 percent, respectively, were immunized. At base line, vaccinated subjects were on average sicker, having higher rates of most coexisting conditions, outpatient care, and prior hospitalization for pneumonia than unvaccinated subjects. Unvaccinated subjects, however, were more likely to have been given a prior diagnosis of dementia or stroke. Vaccination against influenza was associated with a reduction in the risk of hospitalization for cardiac disease (reduction of 19 percent during both seasons [P<0.001]), cerebrovascular disease (reduction of 16 percent during the 1998-1999 season [P<0.018] and 23 percent during the 1999-2000 season [P<0.001]), and pneumonia or influenza (reduction of 32 percent during the 1998-1999 season [P<0.001] and 29 percent during the 1999-2000 season [P<0.001]) and a reduction in the risk of death from all causes (reduction of 48 percent during the 1998-1999 season [P<0.001] and 50 percent during the 1999-2000 season [P<0.001]). In analyses according to age, the presence or absence of major medical conditions at base line, and study site, the findings were consistent across all subgroups. CONCLUSIONS: In the elderly, vaccination against influenza is associated with reductions in the risk of hospitalization for heart disease, cerebrovascular disease, and pneumonia or influenza as well as the risk of death from all causes during influenza seasons. These findings highlight the benefits of vaccination and support efforts to increase the rates of vaccination among the elderly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Influenza vaccination as a population-wide prevention measure was associated with a very cost-effective reduction in clinical events.171”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [171]
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Von Sternberg, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 996
Self-citationInfection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484
Self-citationValidation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
Mac Donald, R., Baken, L., Nelson, A., & Nichol, K. L. (1999) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00159-7 · Cited by 410
Self-citationAcute respiratory-tract infections and risk of first-time acute myocardial infarction
Meier, C. R., Jick, S. S., Derby, L. E., Vasilakis, C., Jick, H., Meier, C., Jick, S., Derby, L., Vasilakis, C., & Jick, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11084-4 · Cited by 389
Vu, T., Farish, S., Jenkins, M., & Kelly, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00041-5 · Cited by 376
Research works printed but not linked: 7
- 2002, MMWR Morb Mortal Wkly Rep, 51, 1
- Nichol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. Oxford, England: Blackwell Science, 1998:358-72.
- Becher H, 2000, J Epidemiol Biostat, 5, 277
- 1999, MMWR Morb Mortal Wkly Rep, 48, 374
- 2000, MMWR Morb Mortal Wkly Rep, 49, 375
- 1997, MMWR Morb Mortal Wkly Rep, 46, 1
- Healthy People 2010: conference edition. Vol. 1. Washington, D.C.: Department of Health and Human Services, January 2000.
Cited by
Items 601–700 of 742
Chun, K., Lee, C. J., Park, H., Jeong, W., Seo, K., Seo, J., Oh, J., Kim, H., Jang, J., Lee, H., et al. (2025) · Korean Circulation Journal · doi:10.4070/kcj.2024.0429 · Cited by 2
“17) Based on these findings, both the American College of Cardiology/American Heart Association and the European Society of Cardiology have recently issued a class IIa recommendation for influenza vaccination in patients with HF. 18)19) Broader population-based studies have shown that influenza vaccination is associat…”
Chothani, A., Shah, N. N., Patel, N., Deshmukh, A. J., Singh, V., Patel, N., Panaich, S., Arora, S., Patel, A., Savani, C., et al. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1064300 · Cited by 2
“Prior studies have suggested vaccination against influenza and pneumococcus to decrease cardiovascular (CV) mortality [1-5].”
BackgroundCost-effective approaches to influenza prevention and treatment
Rothberg, M. B. (2005) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.5.2.141 · Cited by 2
A cluster of deaths following influenza vaccination, Israel, 2006
Anis, E., Leventhal, A., Slater, P. E., Arbeli, Y., Sivan, Y., Berlovitz, Y., Lev, B. I., & Israeli, A. (2010) · Journal of Public Health Policy · doi:10.1057/jphp.2010.22 · Cited by 2
“Other research has found that influenza vaccination is not linked to a shortterm risk of vascular problems or to other, unanticipated postinjection symptoms in the elderly(3,4); that influenza vaccination was associated with a lower risk of MI among those both with and without a prior history of cardiac disease;(5,6)…”
BackgroundEfficacité des vaccins antigrippes chez la personne âgée
Lang, P.-O., Govind, S., & Aspinall, R. (2012) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2012.03.001 · Cited by 2
“Toutes les études, qui par la suite ont ajusté les mesures d’efficacité sur les pathologies associées ou l’état de santé, ont démontré des tendances similaires [9,15,26,34,47—54].”
BackgroundInfluenza: current evidence and informed predictions
Handa, R., Teo, S. S. S., & Booy, R. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.4.443 · Cited by 2
Novel Strategies for Improved Vaccines for the Elderly: The Example of Influenza
Giudice, G. D., & Rappuoli, R. (2011) · Springer eBooks · doi:10.1007/978-3-0346-0219-8_10 · Cited by 2
“In more recent studies, influenza vaccination significantly reduced hospitalization and death in elderly subjects [42], showing an effectiveness of 27% and 48% against hospitalization for pneumonia or influenza and against death, respectively, in communitydwelling elderly subjects [43].”
BackgroundHara, M., & Hirota, Y. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.002 · Cited by 2
Rezaei, N., Kheiri, S., Mousavi, M. S., & Mohammadian-Hafshejani, A. (2023) · Iranian Journal of Public Health · doi:10.18502/ijph.v52i5.12709 · Cited by 2
“In most observational studies with a sample size of more than 10,000 people, the protective role of the influenza vaccine in preventing the hospitalization of the elderly has been confirmed (41, 42).”
BackgroundIndustry and government perspective in influenza control.
Slater, E. E. (2004) · Europe PMC (PubMed Central) · Cited by 2
Role of anti-infective strategies in the prevention of stroke
Grau, A. (2005) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-005-0047-6 · Cited by 2
Lucas, P. C. D. C., Duarte, Y. A. O., Masuda, E. T., Trevisan, C. M., Palasio, R. G. S., Ferreira, P. M., Yu, A. L. F., & Carvalhanas, T. R. M. P. (2021) · Geriatrics Gerontology and Aging · doi:10.53886/gga.e0210040 · Cited by 2
Stacey, R. B., & Schocken, D. D. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_21 · Cited by 2
Cox, M. M. J. (2009) · doi:10.18174/14323 · Cited by 5
“Recent data also suggest that influenza vaccinations play a role in reduction of heart attacks and strokes in the elderly [Nichol et al., 2003].”
BackgroundMethodPrioritizing Influenza Vaccination
Rothberg, M. B. (2004) · JAMA · doi:10.1001/jama.292.21.2582-b · Cited by 2
Vacunación antigripal: ¿nuevas indicaciones de un antiguo tratamiento?
García–Moll, X. (2003) · Revista Española de Cardiología · doi:10.1016/s0300-8932(03)76989-9 · Cited by 2
Influence of advancing age on influenza vaccination effectiveness among community dwelling elderly
Nichol, K. L., Nordin, J. D., Mullooly, J. P., & Lask, R. (2004) · International Congress Series · doi:10.1016/j.ics.2004.02.036 · Cited by 2
Self-citationCiszewski, A. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.078 · Cited by 2
Infection as a risk factor for stroke
Palm, F., & Grau, A. (2006) · Future Neurology · doi:10.2217/14796708.2.1.59 · Cited by 2
“Influenza vaccination was associated with reduced stroke risk in two case-control studies and in one large survey [19–21]; however, causality is not yet proven owing to the possibility of residual confounding in these studies and the lack of randomized intervention studies.”
BackgroundInfluenza Vaccines: Crossing the Translational Gap to Improve Outcomes in the Elderly
McElhaney, J. E., & Nichol, K. L. (2005) · Aging Health · doi:10.2217/1745509x.1.1.167 · Cited by 2
“Vaccine effectiveness remains relatively constant across age and risk groups, at least for community-dwelling elderly [10–13], but the risk for serious complications from influenza increases exponentially with increasing age and comorbidities.”
BackgroundInfluentialSelf-citationEmerging Themes in Epidemiology
Dushoff, J. G. (2005) · Cited by 2
The Impact of Pharmacy-Based Immunization on Vaccination Rates and Prevalence of Influenza Virus
McConeghy, K. W. (2015) · Figshare · Cited by 2
Care after Coronary-Artery Bypass Surgery
Sorokin, R. (2003) · New England Journal of Medicine · doi:10.1056/nejm200307173490322 · Cited by 2
Varotto, E., Cossarizza, A., & Galassi, F. M. (2018) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-018-0287-7 · Cited by 1
Liao, C., Tai, Y., Yeh, C., Hsu, Y., Chen, T.-L., & Cherng, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262420 · Cited by 1
“Although the rates of pneumonia and stroke were lower in the vaccine cohort than in the control cohort, the association did not reach statistical significance, in contrast to some studies [13, 16, 17, 21].”
BackgroundResultAlmulla, M. M., Mansoor, N., Ali, A. M. H., Al‐Majmuei, A., Alatoom, M., Waly, Y. M., Abdelhadi, L., & Alqawasmi, L. M. F. (2025) · Cureus · doi:10.7759/cureus.96396 · Cited by 1
“This observation is consistent with findings from Sullivan et al. and Nichol et al., who demonstrated that getting vaccinated every year improves both vaccine performance and overall health outcomes [14,15].”
Mora, T., Martínez, M., & Cabezas, C. (2025) · BMJ Public Health · doi:10.1136/bmjph-2025-002698 · Cited by 1
Hashim, A. B., McKeever, T. M., Kelly, S., & Nguyen‐Van‐Tam, J. S. (2010) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2010.09.007 · Cited by 1
“[3] Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M.”
BackgroundArteriosclerosis. Factores de riesgo cardiovascular
Bayod, C., Villarroel, M. T., Lorenz, J. B. P., & Puzo, J. (2013) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(13)70635-8 · Cited by 5
Kamusheva, M., Dimitrova, M. J., Mitov, K., & Petrova, G. I. (2015) · World Journal of Pharmacy and Pharmaceutical Sciences · Cited by 1
Konservative Therapie der stabilen koronaren Herzkrankheit
Custodis, F., & Laufs, U. (2012) · Herz · doi:10.1007/s00059-011-3578-5 · Cited by 1
Vaccines for adults: a review of recent literature
Ahmed, M., Alorinan, B., AlYemni, A., Albakri, M., Alahmari, M., Hassan, A., Alrahili, A. S., Alfawzan, A., Alazzouni, A., & Alansari, A. (2018) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20184601 · Cited by 1
“associated with a significant decrease in the incidence of pneumonia, cardiovascular diseases, and cerebrovascular diseases by 29%, 19%, and 23%, respectively [9].”
BackgroundLee, E., Kwon, O. D., & Kim, S. J. (2021) · Vaccines · doi:10.3390/vaccines9070763 · Cited by 1
Vaccination in Prevention of Acute Cardiovascular Events in Adults
Sinha, S. C., & Reddy, G. V. (2024) · Indian Journal of Clinical Cardiology · doi:10.1177/26324636241231639 · Cited by 1
Human Monoclonal Antibodies for Prophylaxis and Treatment of Influenza
Koudstaal, W., UytdeHaag, F. G. C. M., Friesen, R. H., & Goudsmit, J. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0279-2_17 · Cited by 2
Smit, P. M., Veldhuis, S., Mulder, J. W., Roggeveen, C., Rimmelzwaan, G. F., Meijers, J. C. M., Beijnen, J. H., & Brandjes, D. P. M. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04413.x · Cited by 1
Preventing Infections and Healthy Aging
McElhaney, J. E., Andrew, M. K., McNeil, S., & Kuchel, G. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-06200-2_16 · Cited by 1
Pneumonie im hohen Lebensalter
Frohnhofen, H., & Stieglitz, S. (2021) · Der Pneumologe · doi:10.1007/s10405-021-00388-z · Cited by 2
Introduction to vaccine development
Odneal, K. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814357-5.00012-x · Cited by 1
Déclaration sur la vaccination antigrippale pour la saison 2012-2013
(CCNI), C. C. N. D. L. (2012) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v38i00a02f · Cited by 1
Déclaration sur le vaccin trivalent inactivé (VTI) contre la grippe pour la saison 2010-2011
(CCNI), C. C. N. D. L. (2010) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v36i00a06f · Cited by 3
Avaliação situacional de Influenza pós pandemia de 2009 - uma breve revisão
Gomes, É. V. R., Tolentino, F. M., de Santi, M. P., Montanha, J. O. M., & Watanabe, A. S. A. (2015) · Hansenologia Internationallis hanseníase e outras doenças infecciosas · doi:10.47878/hi.2015.v40.35006 · Cited by 1
Kikuchi, H., Kawasaki, S., Nakayama, H., Saito, N., Shimada, H., Miyazaki, S., Sakai, S., & Suzuki, M. (2010) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.43.461 · Cited by 1
Influenza: Vaccination and Treatment
Karassa, F. B., & Ioannidis, J. P. A. (2005) · Wiley eBooks · doi:10.1002/9780470987377.ch27 · Cited by 1
An Overview of Pneumonia in Community and Hospital Settings
Gin, A. S. (2005) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v58i4.317 · Cited by 1
“Influenza vaccination reduced the risk of hospital admission due to pneumonia, cardiac disease, and cerebrovascular disease by 32%, 19%, and 16%, respectively, and the risk of death by 48%.(54) The importance of vaccinating health care workers was demonstrated by Carman and others,(55) who found that the mortality rat…”
BackgroundBrocas, E., Cormier, P., Barouk, J., van de Louw, A., & Tenaillon, A. (2008) · La Presse Médicale · doi:10.1016/j.lpm.2007.11.017 · Cited by 1
Agustí, M. L. M., Raya, P. R., Mas, A., Moreno-Millán, N., Serra-Torres, A., & Llor-Vila, C. (2006) · Vacunas · doi:10.1016/s1576-9887(06)73171-5 · Cited by 1
Vacunación antigripal: ¿todo ventajas?
Campins, M., & Alemany, L. (2003) · Medicina Clínica · doi:10.1016/s0025-7753(03)74069-x · Cited by 2
Järvinen, A., Joutseno, J., & Gyldmark, M. (2007) · Journal of Medical Economics · doi:10.3111/13696990701427747 · Cited by 1
“Separate analyses were carried out for the following distinct groups of patients: (1) otherwise healthy adults (i.”
BackgroundInfluentialGrau, A. (2011) · Stroke · doi:10.1161/strokeaha.110.609123 · Cited by 1
Vaccinaties en ouderen: een update
Carels, T., & Flamaing, J. (2005) · Tijdschrift voor Gerontologie en Geriatrie · doi:10.1007/bf03074740 · Cited by 2
Vaccine for Atherosclerosis: An Emerging New Paradigm
Shah, P. K., Chyu, K., Nilsson, J. Å., & Fredrikson, G. N. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-179-0_50 · Cited by 1
“Several observational studies have suggested that influenza vaccination is associated with reduced cardiovascular events, such as myocardial infarction, out-of-hospital cardiac arrest, stroke or incidences of hospital admission [ 54 , 55].”
BackgroundGohlke, H., Albus, C., Bönner, G., Darius, H., Eckert, S., Gohlke-Bärwolf, C., Gysan, D. B., Hahmann, H., Halle, M., Hambrecht, R., et al. (2012) · Der Kardiologe · doi:10.1007/s12181-012-0421-z
Moura, R. F. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2013.tde-11112013-105957 · Cited by 3
New Developments in Treatment of Vulnerable Plaques
Madjid, M., Litovsky, S. H., Willerson, J. T., & Casscells, S. W. (2006) · Wiley eBooks · doi:10.1002/9780470987575.ch21
Treating Systolic Heart Failure
Rao, V. U., & Teerlink, J. R. (2010) · Wiley eBooks · doi:10.1002/9780470669402.ch13
Ngeh, J. K. T. (2008) · The University of Bath Online Publications Store (The University of Bath)
El ensayo FLUVACS en perspectiva
Gurfinkel, E. (2004) · Revista Española de Cardiología
de Oliveira, F. J., & da Motta, L. B. (2007) · Revista Hospital Universitário Pedro Ernesto
[Acute respiratory tract infections and acute coronary syndromes].
KELLER, T. T., Mairuhu, A. T. A., Gerdes, V. E. A., Brandjes, D. P. M., Peters, R. J. G., & Gorp, E. C. M. V. (2005) · PubMed
Gohlke, H., Albus, C., Bönner, G., Darius, H., Eckert, S., Gohlke-Bärwolf, C., Gysan, D. B., Hahmann, H., Halle, M., Hambrecht, R., et al. (2013) · Der Kardiologe · doi:10.1007/s12181-012-0468-x · Cited by 1
Prevención de la neumonía adquirida en la comunidad
Manuel Barros, M., Claudia Cartagena, S., & Luis Bavestrello, F. (2005) · Revista chilena de enfermedades respiratorias · doi:10.4067/s0717-73482005000200009 · Cited by 1
Kardiovaskuläres Risiko des urämischen Patienten
Ketteler, M., Sigala, F., Hepp, W., & Girndt, M. (2009) · Steinkopff eBooks · doi:10.1007/978-3-7985-1572-7_10
Estudo G.R.I.P.E. (Garantia de Receituário Incentivado pelo Especialista)
Familiar, I. D. M. G. E., Macedo, A., Filipe, E., Familiar, I. D. M. G. E., GUERRA, E. S., Familiar, I. D. M. G. E., Pamplona, P., Familiar, I. D. M. G. E., Cardoso, S., & Familiar, I. D. M. G. E. (2009) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v25i1.10585
Pathways to Further Boost Treatment Rates and Clinical Outcomes in Hospitalized Stroke Patients
Ovbiagele, B. I. (2010) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0b013e3181cd5c84
Monthly admissions for heart failure (HF)— Environmental links
Stoupel, E. G., Abramson, E., & Shapiro, M. (2014) · Health · doi:10.4236/health.2014.65062
“In an additional study related to circannual death distribution it was shown that this process is rhythmic and the acrophase for total deaths number, cardiac origin and stroke related deaths are in February, with small time differences by gender and each of the mentioned etiologies [16,17,21].”
BackgroundWicker, S., & Rose, M. A. (2009) · Public Health Forum · doi:10.1016/j.phf.2009.03.013
“Zahlreiche Studien zeigen jedoch, dass Influenza-bedingte Erkrankungen (Wang et al., 2007), Hospitalisierungen (Nichol et al., 2003) und Todesfälle (Carman et al., 2000; Potter et al., 1997) bei älteren Menschen im stationären Bereich von Pflegeinstitutionen markant vermindert werden können,…”
BackgroundAMI – ‘Acquired Microbe Invasion’?
Jespersen, C. M. (2004) · Heart Drug · doi:10.1159/000077706
Duarte, R. M. R., & Donalísio, M. R. (2009) · Epidemiologia e Serviços de Saúde · doi:10.5123/s1679-49742009000200008 · Cited by 5
Grajewski, J., Slusar, M., & Hayney, M. S. (2007) · Journal of the American Pharmacists Association · doi:10.1331/japha.2007.07525
Immunosenescence Modulation by Vaccination
McElhaney, J. E. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_71
“The fact that these vaccines also prevent complications of influenza (pneumonia, heart attacks, strokes and exacerbations of congestive heart failure) provides an even greater incentive to increase the use of existing vaccines and develop new vaccines that are targeted to improve the senescent immune response [6, 7] .”
BackgroundStable coronary artery disease - diagnostics and therapy
Laufs, U. (2006) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2006-933696
Adult Immunizations: An Update
Wolfert, A. L., & Rozwadowski, J. M. (2003) · Primary Care Case Reviews · doi:10.1097/01.mpc.0000083474.85114.e9
Recomendaciones de vacunación para adultos mayores de 60 años
Gil‐Gregorio, P., Salazar, J. R., Cordero, P. R., Rodríguez, J. G., Pascual, C., Trigo, J. A. L., Moreno, N., Cancer, R. C., Sanmartí, L. S., Armengol, J. G., et al. (2011) · Vacunas · doi:10.1016/s1576-9887(11)70007-3
Innate Immune Responses in the Geriatric Population
Compt, N., & Goriely, S. (2012) · InTech eBooks · doi:10.5772/37878 · Cited by 3
“Studies have shown that vaccination above the age of 65 decreased the risk of acute coronary syndrome (Nichol et al., 2003; Lundberg & Hansson, 2010).”
BackgroundRoyo‐Bordonada, M. Á., Bejarano, J. M. L., Álvarez, F. V., Sans, S., Pérez, A., Pedro‐Botet, J., Carriles, R. M. M., Maiques, A., Lizcano‐Álvarez, A., Lizarbe, V., et al. (2013) · Avances en Diabetología · doi:10.1016/j.avdiab.2013.04.002
Kaltenbach, M. (2008) · Steinkopff eBooks · doi:10.1007/3-7985-1615-4_1
Vaccines for Hypertension and Atherosclerosis
Sasamura, H., Azegami, T., & Itoh, H. (2013) · Springer eBooks · doi:10.1007/978-3-319-00978-0_1
Hinchey, J. A., Howard, V. J., Jauch, E. C., Levine, S. R., Meschia, J. F., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2012)
Meschia, J. F., Moore, W. S., Pearson, T. A., Hart, R. G., Hinchey, J. A., Howard, V. J., Jauch, E. C., Chaturvedi, S., Creager, M. A., Culebras, A., et al. (2010)
Recent Advances in the Management of Viral Flu Infections
Pitliya, P., Garg, S. K., Saini, P., Pareek, A., Trivedi, S. K., Puri, D., & Bhambu, S. (2013) · International Journal of Pharmaceutical Sciences and Nanotechnology · doi:10.37285/ijpsn.2013.6.4.1
“Vaccination: The single best way to prevent the flu is to get a flu vaccine each season (LaMontagne et al., 1983; Quinnan et al., 1983; Barker and Mullooly, 1980; Patriarca et al., 1985; Nichol et al., 1994; Nichol et al., 2003).”
Meschia, J. F., Moore, W. S., Hart, G. L. W., Hinchey, J. A., Howard, V. J., Jauch, E. C., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., et al. (2011)
Laosiritaworn, Y. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Royo‐Bordonada, M. Á., Bejarano, J. M. L., Alvarez, F. V., Sans, S., Pérez, A., Pedro‐Botet, J., Carriles, R. M. M., Maiques, A., Lizcano, Á., Lizarbe, V., et al. (2016) · Neurología (English Edition) · doi:10.1016/j.nrleng.2013.03.009 · Cited by 2
Mgbor, N., & Umeh, R. E. (2002) · PubMed
COPD — zukünftige Therapieoptionen: Was können wir mittelfristig erwarten?
Virchow, J. C. (2006) · Der Pneumologe · doi:10.1007/s10405-006-0086-z
Flu Vaccine for Cardiovascular Prevention in the Elderly
Krumholz, H. M., & Sm (2003) · Journal watch · doi:10.1056/jc200305090000001
Treatment of Neuropsychiatric Symptoms in Patients with Dementia
Simonsen, L., Ta, R., & Blackwelder, W. C. (2007)
Methods for preventing pneumonia
Torres, A., & Cillóniz, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-22062-8_5
Alternatives to randomized trials for estimating treatment effects
Newman, T. B., & Kohn, M. A. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511759512.011
Mittapally, V. K., & Lanka, D. (2015) · Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences
Chronic Obstructive Lung Disease in the Elderly
Most, J. F., & Rochester, C. L. (2015) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814635011_0014
Balcioglu, H. A., Ulus, T., Sarı, Y. E., Bilge, U., & Ünlüoğlu, İ. (2016) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.56189
Khajotia, R. R., & Sree Raman, K. (2016) · Journal of Clinical Respiratory Diseases and Care · doi:10.4172/2472-1247.1000118
“Even so, annual influenza vaccination and pneumococcal vaccination should be given to all patients in an effort to reduce both morbidity and mortality [77,78].”
BackgroundSalvioli, G., Gori, Z., Cavallini, G., Donati, A., Bergamini, E., & Mussi, C. (2005)
Bertholom, C. (2017) · Option/Bio · doi:10.1016/s0992-5945(17)30101-0
Vaccine in Belgium During the 2010-2011 Influenza Season
Dhont, P., Albert, A., Brenders, P., Podwapinska, A., Pollet, A., Scheveneels, D., Tihon, F., Verheyden, I., Victor, J., & Samson, S. (2012)
Grishyna, O., Бабинец, Л. С., Menkus, O., & Myroshnychenko, T. M. (2017) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs02.03.043
Supporting Microvasculature Function
Haverich, A., & Boyle, E. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-20245-3_7
Metadata
- Authors
- Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., & Iwane, M.
- Affiliations
- University of Minnesota (US)
- HealthPartners (US)
- Kaiser Permanente (US)
- Centers for Disease Control and Prevention (US)
- ORCID
- Nordin, James
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1322-1332
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2116971894
- Cited by
- 752
- References
- 42
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 10 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 23 · 2019: 26 · 2018: 29 · 2017: 25 · 2016: 19 · 2015: 33 · 2014: 29 · 2013: 42 · 2012: 50
- FWCI
- 45.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- influenza vaccination, influenza, stroke, heart disease, hospitalization, older adults, pneumonia, mortality, ischemic heart disease, cerebrovascular disease, upper respiratory tract infection, managed care, community-dwelling older adults, vaccine effectiveness, dementia, comorbidities, subgroup analysis
- MeSH terms
- Aged, Aged, 80 and over, Female, Heart Diseases, Hospitalization, Humans, Influenza, Human, Influenza Vaccines, Male, Mortality, Pneumonia, Risk, Logistic Models, Odds Ratio, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.